Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Response to “Unexpected mutations after CRISPR–Cas9 editing in vivo

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Schaefer, K.A. et al. Nat. Methods 14, 547–548 (2017).

    Article  CAS  Google Scholar 

  2. Saunders, C.T. et al. Bioinformatics 28, 1811–1817 (2012).

    Article  CAS  Google Scholar 

  3. Cibulskis, K. et al. Nat. Biotechnol. 31, 213–219 (2013).

    Article  CAS  Google Scholar 

  4. Rimmer, A. et al. Nat. Genet. 46, 912–918 (2014).

    Article  CAS  Google Scholar 

  5. Kim, D. et al. Nat. Methods 12, 237–243 (2015).

    Article  CAS  Google Scholar 

  6. Cho, S.W., Kim, S., Kim, J.M. & Kim, J.-S. Nat. Biotechnol. 31, 230–232 (2013).

    Article  CAS  Google Scholar 

  7. Cho, S.W. et al. Genome Res. 24, 132–141 (2014).

    Article  CAS  Google Scholar 

  8. Smith, C. et al. Cell Stem Cell 15, 12–13 (2014).

    Article  CAS  Google Scholar 

  9. Veres, A. et al. Cell Stem Cell 15, 27–30 (2014).

    Article  CAS  Google Scholar 

  10. Suzuki, K. et al. Cell Stem Cell 15, 31–36 (2014).

    Article  CAS  Google Scholar 

  11. Iyer, V. et al. Nat. Methods 12, 479 (2015).

    Article  CAS  Google Scholar 

  12. Tsai, S.Q. et al. Nat. Biotechnol. 33, 187–197 (2015).

    Article  CAS  Google Scholar 

  13. Frock, R.L. et al. Nat. Biotechnol. 33, 179–186 (2015).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

J.-S.K. is supported by a grant from the Institute for Basic Science (IBS-R021-D1).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Matthias Schlesner or Jin-Soo Kim.

Ethics declarations

Competing interests

J.-S.K. is a cofounder of and holds stocks in ToolGen, Inc., a company focused on therapeutic genome editing. All the other authors declare no competing financial interests.

Integrated supplementary information

Supplementary Figure 1

(a) Sample-specific SNVs in all pairwise combinations F03, F05, and FVB (WT) (A vs B means variants present in B and not in A). All three aligned sequencing data representing WT (SRR5450998), F03 (SRR5450997), and F05 (SRR5450996) were retrieved and analyzed using Strelka and Mutect. All SNVs were filtered using dbSNP 143 and mouse genome project v5. (b,c) Venn diagrams showing homozygous (blue) and heterozygous (red) SNVs (b) and indels (c) found in the wild-type control mouse (FVB) and the two gene-edited mice (F03 and F05). Variants were identified with Platypus (v. 1.0.8) with multi-sample callingmode with default parameters; variants with coverage lower than 15 in any of the samples, and multi-allelic variants are not considered.

Supplementary information

Supplementary Text and Figures

Supplementary Figure 1 and Supplementary Notes 1–2 (PDF 165 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, ST., Park, J., Kim, D. et al. Response to “Unexpected mutations after CRISPR–Cas9 editing in vivo”. Nat Methods 15, 239–240 (2018). https://doi.org/10.1038/nmeth.4554

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nmeth.4554

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing